Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Horama Joins Race To Develop Gene Therapies For Eye Diseases

Executive Summary

Initial VC and institutional funding from a French syndicate will support further drug development at Paris-based Horama, which aims to put two targeted gene therapies for hereditary retinitis pigmentosa in the clinic by 2018.

Advertisement

Related Content

OptiKira Pursuing A Novel Small-Molecule Approach To Retinitis Pigmentosa
Spark Acquires Irish Ophthalmology Partner
Deal-happy Roche acquires Trophos

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register